Related Experiment Video

Updated: Jul 29, 2026

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.8K

Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab

Zi-Yi Choo1, Adesola A Akinyemi2, Thomas Cibull2

  • 1Pritzker School of Medicine, University of Chicago, Chicago, Illinois.

JAAD Case Reports
|March 10, 2023
PubMed
Abstract

No abstract available in PubMed .

Keywords:
AITL, angioimmunoblastic T-cell lymphomaCD, cluster of differentiationCTCL, cutaneous T-cell lymphomaangioimmunoblastic T-cell lymphomaatopic dermatitisbiologicsdupilumabmedical dermatologyperipheral T-cell lymphoma

More Related Videos

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells10:19

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

1.3K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.2K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.